Goldman Sachs downgrades StoneCo stock rating on earnings concerns By Investing.com

Goldman Sachs downgraded StoneCo to Neutral from Buy and cut its price target to $14 from $20, citing weaker TPV growth, market share losses versus PAGS, and limited room for multiple expansion. The firm sees 6% downside to 2026E net income and expects earnings momentum to deteriorate, even as StoneCo prepares to distribute R$3 billion of excess cash from the Linx divestiture as extraordinary dividends on May 4. Shares are already near the 52-week low at $11.66 vs. $11.58.

Analysis

This is less about a one-day de-rating and more about the market repricing StoneCo’s earnings quality. When TPV growth lags peers, the downside is nonlinear: operating leverage works in reverse, so every incremental miss bleeds more through margins than the headline revenue gap suggests. The key second-order effect is competitive: PAGS can use an easier comp base and perceived execution momentum to win merchant share precisely while STNE is forced to defend price and incentives, which can keep dispersion wide into the next 2-3 quarters.

The cash-return catalyst is real, but it may be more psychological than fundamental. Extraordinary dividends can support the stock for a few sessions, yet they do not fix the core issue that the market wants recurring growth visibility, not balance-sheet recycling. Once the payout is digested, the absence of a credible reinvestment catalyst leaves the multiple vulnerable to “value trap” framing, especially with the stock already near lows and consensus revisions still rolling through.

Near term, the cleanest risk is a miss-and-cut cycle around the next print: if management confirms slowing TPV or softer 2026 guidance, the stock can re-rate another 15-20% lower before bargain hunters step in. The main bull case is that expectations are now compressed enough that any sign of stabilization in merchant acquisition or take-rate discipline could trigger a relief rally, but that likely requires at least one quarter of clean execution rather than a capital-return headline. In that sense, the catalyst path is asymmetric: downside is immediate and fundamental, upside is delayed and evidence-based.

The contrarian angle is that the market may be over-discounting a cyclical slowdown as structural share loss. With STNE at a very low earnings multiple, even modest stabilization in TPV or margins could produce outsized upside because positioning is likely already light and the stock is trading as if the business has permanently de-rated. That said, the bar for a durable re-rating is high: investors need proof that the company can grow without relying on payout optics or a benign comp base.

Key Decisions for Investors

• Short STNE into the next earnings window (May 14) or on any post-dividend strength; thesis is another 15-20% downside if TPV or guidance disappoints, with risk defined by a stabilization print.
• Pair trade: long PAGS / short STNE over the next 1-3 months to express relative execution divergence; PAGS has the cleaner catalyst path and should outperform if the market continues to reward easier comps and share gains.
• Sell upside in STNE via call spreads rather than outright short if you expect dividend-related support in the near term; cap loss while monetizing the likely post-event fade.
• For contrarian accounts, consider a small starter long only after earnings if management shows clear TPV stabilization and margin discipline; use a tight stop because the burden of proof is on the next print, not the balance sheet.
• Avoid adding capital on the extraordinary dividend alone; treat it as a one-off cash return, not a valuation reset, and reassess only after the market sees whether the payout is followed by renewed share loss.